Caribou Biosciences Statistics
Total Valuation
CRBU has a market cap or net worth of $148.77 million. The enterprise value is $51.14 million.
| Market Cap | 148.77M |
| Enterprise Value | 51.14M |
Important Dates
The next estimated earnings date is Friday, August 7, 2026, after market close.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CRBU has 99.18 million shares outstanding. The number of shares has increased by 3.32% in one year.
| Current Share Class | 99.18M |
| Shares Outstanding | 99.18M |
| Shares Change (YoY) | +3.32% |
| Shares Change (QoQ) | +1.40% |
| Owned by Insiders (%) | 4.41% |
| Owned by Institutions (%) | 46.80% |
| Float | 94.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.75 |
| Forward PS | 6.14 |
| PB Ratio | 1.39 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.22, with a Debt / Equity ratio of 0.26.
| Current Ratio | 6.22 |
| Quick Ratio | 6.10 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -83.46% and return on invested capital (ROIC) is -39.37%.
| Return on Equity (ROE) | -83.46% |
| Return on Assets (ROA) | -34.69% |
| Return on Invested Capital (ROIC) | -39.37% |
| Return on Capital Employed (ROCE) | -101.84% |
| Weighted Average Cost of Capital (WACC) | 14.11% |
| Revenue Per Employee | $115,495 |
| Profits Per Employee | -$1.37M |
| Employee Count | 97 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -550,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.08% in the last 52 weeks. The beta is 2.28, so CRBU's price volatility has been higher than the market average.
| Beta (5Y) | 2.28 |
| 52-Week Price Change | -23.08% |
| 50-Day Moving Average | 1.80 |
| 200-Day Moving Average | 1.88 |
| Relative Strength Index (RSI) | 36.11 |
| Average Volume (20 Days) | 1,767,019 |
Short Selling Information
The latest short interest is 11.59 million, so 11.69% of the outstanding shares have been sold short.
| Short Interest | 11.59M |
| Short Previous Month | 9.63M |
| Short % of Shares Out | 11.69% |
| Short % of Float | 12.23% |
| Short Ratio (days to cover) | 4.25 |
Income Statement
In the last 12 months, CRBU had revenue of $11.20 million and -$133.22 million in losses. Loss per share was -$1.41.
| Revenue | 11.20M |
| Gross Profit | -81.40M |
| Operating Income | -117.29M |
| Pretax Income | -133.77M |
| Net Income | -133.22M |
| EBITDA | -128.58M |
| EBIT | -131.71M |
| Loss Per Share | -$1.41 |
Balance Sheet
The company has $117.63 million in cash and $26.95 million in debt, with a net cash position of $91.68 million or $0.92 per share.
| Cash & Cash Equivalents | 117.63M |
| Total Debt | 26.95M |
| Net Cash | 91.68M |
| Net Cash Per Share | $0.92 |
| Equity (Book Value) | 102.02M |
| Book Value Per Share | 1.05 |
| Working Capital | 102.71M |
Cash Flow
In the last 12 months, operating cash flow was -$101.25 million and capital expenditures -$389,000, giving a free cash flow of -$101.64 million.
| Operating Cash Flow | -101.25M |
| Capital Expenditures | -389,000 |
| Depreciation & Amortization | 3.13M |
| Net Borrowing | n/a |
| Free Cash Flow | -101.64M |
| FCF Per Share | -$1.02 |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,046.91% |
| Pretax Margin | -1,194.05% |
| Profit Margin | n/a |
| EBITDA Margin | -1,147.75% |
| EBIT Margin | -1,175.68% |
| FCF Margin | n/a |
Dividends & Yields
CRBU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.32% |
| Shareholder Yield | -3.32% |
| Earnings Yield | -93.28% |
| FCF Yield | -71.17% |
Analyst Forecast
The average price target for CRBU is $12.00, which is 700.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 700.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 46.48% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRBU has an Altman Z-Score of -5.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.53 |
| Piotroski F-Score | 3 |